NEW YORK (GenomeWeb) – Swiss clinical genomics analysis firm Sophia Genetics announced today it has obtained CE-IVD marking for a solution to detect copy number variations in BRCA1 and BRCA2 genes. 

The company has developed an algorithm that directly detects CNVs from next-generation sequencing data. Using the firm's data-driven medicine platform, clinicians can detect all variant types for BRCA1/2 genes in one experiment, it said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.